8-K: Aehr Test Systems Reports Mixed Q2 Results, Diversifies into AI and GaN Markets

Aehr Test Systems announced its second quarter fiscal 2025 results, showing a decrease in revenue and a net loss, but highlighted significant progress in diversifying into new markets like AI and GaN.

Summary

• Aehr Test Systems reported a net revenue of $13.5 million for the second quarter of fiscal year 2025, down from $21.4 million in the same quarter of the previous year.
• The company experienced a GAAP net loss of $1.0 million, or $(0.03) per diluted share, compared to a net income of $6.1 million, or $0.20 per diluted share, in the second quarter of fiscal 2024.
• Non-GAAP net income was $0.7 million, or $0.02 per diluted share, compared to $6.7 million, or $0.23 per diluted share, in the prior year's second quarter.
• Bookings for the quarter were $9.2 million, and the backlog as of November 29, 2024, was $12.4 million, with an effective backlog of $26.6 million including subsequent bookings.
• The company's total cash, cash equivalents, and restricted cash decreased to $35.2 million from $40.8 million at the end of the previous quarter.
• For the first six months of fiscal 2025, net revenue was $26.6 million, down from $42.1 million in the same period of fiscal 2024, and the GAAP net loss was $(0.4) million, or $(0.01) per diluted share.
• Non-GAAP net income for the first six months was $2.8 million, or $0.10 per diluted share, compared to $11.9 million, or $0.40 per diluted share, in the prior year.
• Cash used in operating activities for the first six months of fiscal 2025 was $3.5 million.
• Aehr secured its first AI processor customer for wafer level burn-in and first volume production orders from an AI processor customer for package part burn-in.
• The company also secured its first gallium nitride (GaN) customer for high-volume production wafer level burn-in.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with significant revenue and profit declines, but also highlights positive developments in new markets. The reiteration of full-year guidance provides some reassurance, but the overall sentiment is neutral to slightly negative due to the current financial results.

Positives

• Aehr has successfully diversified into new high-growth markets such as AI processors and GaN semiconductors.
• The company secured its first AI processor customer for both wafer level and package part burn-in.
• Aehr has expanded its product reach into additional large and fast-growing markets.
• The acquisition of Incal Technology has accelerated market diversification, particularly in AI processors.
• The company has a strong customer base in the silicon carbide market and is engaged in benchmarking efforts with potential new customers.
• Aehr is well-positioned to capitalize on the growth in the overall semiconductor market by addressing the critical reliability needs of next-generation applications.
• The company is maintaining its full-year financial guidance.

Negatives

• Net revenue decreased to $13.5 million in Q2 2025 from $21.4 million in Q2 2024.
• The company reported a GAAP net loss of $1.0 million in Q2 2025, compared to a net income of $6.1 million in Q2 2024.
• Non-GAAP net income also decreased to $0.7 million in Q2 2025 from $6.7 million in Q2 2024.
• Cash used in operating activities was $3.5 million for the first six months of fiscal 2025.
• The company experienced a decrease in total cash, cash equivalents, and restricted cash from $40.8 million to $35.2 million.
• Silicon carbide revenue growth is expected to be challenging outside of China before recovering in calendar 2026.

Risks

• The company faces geopolitical, trade, and intellectual property risks associated with the Chinese market.
• Aehr has filed a lawsuit in China against a local supplier for intellectual property infringement.
• Recent trade-related developments in the U.S. and competitive offerings in China have heightened the risk associated with bookings and revenue from Chinese customers.
• Quarterly revenue can experience significant variability if system orders are delayed.
• The company's current fiscal year forecast includes contemplated orders and revenue yet to be booked for silicon carbide wafer level burn-in systems and WaferPaks destined for silicon carbide manufacturers in China.

Future Outlook

Aehr is optimistic about its current and emerging market opportunities and maintains its previously stated financial guidance for the fiscal year ending May 30, 2025, with total revenue of at least $70 million and non-GAAP net profit before taxes of at least 10% of revenue. The company believes it is well-positioned for long-term, sustainable growth.

Management Comments

• Gayn Erickson, President and CEO of Aehr Test Systems, commented that they achieved significant progress on key objectives, expanding product reach into additional large and fast-growing markets.
• Erickson noted that market diversification into AI processors, gallium nitride power semiconductors, data storage devices, silicon photonics integrated circuits, and flash memory is driving new opportunities.
• Management believes they are particularly well positioned to capitalize on opportunities in the rapidly growing AI semiconductor market with the ultra-high power Sonoma product line.
• Aehr estimates that the combined wafer level and package part reliability test and production burn-in market for AI processors will exceed $100 million annually in the future.
• Management is excited about the opportunity for production burn-in and stabilization of devices used in hard disk drives.
• Aehr believes its innovative solutions are poised to capitalize on the growth in the overall semiconductor market by addressing the critical reliability needs of next-generation applications.

Industry Context

Aehr's diversification into AI and GaN markets aligns with the broader industry trend of increasing demand for advanced semiconductors in these sectors. The company's focus on reliability testing is also crucial given the growing complexity and performance requirements of modern semiconductors. The expansion into AI and GaN markets is a strategic move to reduce reliance on the silicon carbide market, which is facing challenges outside of China.

Comparison to Industry Standards

• Aehr's move into AI processor testing puts them in competition with companies like Teradyne and Advantest, who also offer testing solutions for high-performance computing chips.
• The GaN market is seeing increased activity from companies like Infineon and STMicroelectronics, who are developing and manufacturing GaN devices, creating a market for testing solutions like Aehr's.
• The silicon carbide market is dominated by companies like Wolfspeed and ON Semiconductor, and Aehr's engagement with these companies and others in the market is crucial for their growth in this sector.
• Aehr's focus on wafer-level burn-in is a niche area, but it is becoming increasingly important as semiconductor manufacturers seek to improve the reliability of their devices before packaging.
• The company's acquisition of Incal Technology and its Sonoma product line is a direct response to the growing demand for package part burn-in solutions, particularly in the AI market.

Legal Proceedings

• Aehr has filed a lawsuit in China against a local supplier for intellectual property infringement related to wafer level burn-in of silicon carbide devices.

Stakeholder Impact

• Shareholders may be concerned about the decreased revenue and net loss in the second quarter, but encouraged by the diversification into new markets.
• Employees may be impacted by the company's performance and strategic shifts.
• Customers will benefit from the company's expanded product offerings and focus on reliability.
• Suppliers may see changes in demand based on the company's market diversification.
• Creditors will be monitoring the company's financial performance and cash flow.

Next Steps

• Aehr will continue to expand its presence in the AI, GaN, and silicon carbide markets.
• The company will focus on securing additional orders for its FOX-XP and Sonoma systems.
• Aehr will continue to collaborate with its lead customer for hard disk drive burn-in.
• The company will monitor and address the risks associated with the Chinese market, including the intellectual property lawsuit.
• Aehr will host a conference call and webcast to discuss its second quarter fiscal 2025 operating results.

Key Dates

Keywords

semiconductor test, burn-in equipment, AI processors, gallium nitride, silicon carbide, wafer level burn-in, package part burn-in, FOX-XP, Sonoma, data storage, semiconductor reliability